Accounting Manager

Are you ready to join Connecticut Innovation’s vibrant community of innovators? Connecticut Innovations (“CI”) is Connecticut’s strategic venture capital arm, and we are passionate about serving our portfolio of 220+ companies across various industries, with strengths in life sciences, technology, and climate tech.

Come join First-in-Class Dermatology Drugs | Veradermics!

Veradermics is a dermatologist-founded, late clinical-stage biopharmaceutical company focused on developing innovative therapeutics to address pervasive treatment challenges in highly prevalent aesthetic and dermatological conditions.

In October 2025, Veradermics announced the closing of an oversubscribed $150 million Series C financing with top-tier healthcare investors. The financing will enable Veradermics to advance the development of our lead candidate, VDPHL
01, as an oral, non-hormonal treatment for men and women with pattern hair loss (PHL). We are currently conducting three Phase 3 clinical trials as we work to deliver potentially transformative solutions and aspire to redefine the standard of care in dermatology. Learn more here.

At Veradermics, we combine scientific rigor with a vision for impactful innovation to make a lasting difference in the lives of patients.

• You Can Be Part of a Meaningful Mission - Veradermics aims to become a leader in medical dermatology by bringing pharmaceutical innovation to the treatment of common skin conditions to improve the lives of patients.
• Veradermics is Growing – Veradermics is a dynamic and growing company; we are advancing our VDPHL
  01 Phase 3 clinical trials and preparing for commercialization; PHL affects approximately 80 million people in the U.S. alone.
• The Veradermics Culture – we are an innovative, collaborative, hard-working and performance-driven company that values the contributions of our employees and keeps our focus on patients
• We have been featured in Forbes, Allure, Marie Claire, Bazaar, Dermatology Times, the Slate, The New York Post, The Hartford Courant, The Kansas City Star, and other multi-media platforms.

The Accounting Manager will be a hands-on owner of core accounting activities, responsible for driving accurate, timely financial close processes while helping to build scalable accounting practices. This role reports to the Controller, and will partner with the CFO, Director of FP&A, and cross-functional teams to ensure accounting operations keep pace with the company's growth.

This position is ideal for someone who thrives in a fast-moving environment, enjoys owning the details while keeping the full picture in mind, and is comfortable building process where needed.

• Own and execute key aspects of the monthly, quarterly, and annual close
• Prepare and review journal entries, accruals, and account reconciliations
• Ensure accurate accounting in accordance with U.S. GAAP
• Understand the full financial picture and proactively identify and resolve issues
• Support accounting for R&D and clinical trial activities, including vendor and CRO spend
• Partner cross-functionally to ensure timely and accurate expense recognition

• Serve as a lead preparer with strong technical understanding of accounting entries and reconciliations
• Help design, document, and improve accounting processes and internal controls
• Partner with the Controller to support audit readiness and compliance initiatives

• Build strong working relationships with FP&A, Clinical Operations, Legal, and other teams
• Communicate accounting requirements clearly and effectively to non-finance stakeholders
• Support budgeting and forecasting processes through close coordination with FP&A

• Support external audits and reviews, including preparation of schedules and documentation
• Manage and oversee processes involving external vendors and service providers

• Bachelor's degree in Accounting or related field (CPA preferred)
• 5–8+ years of progressive accounting experience in biotech, life sciences, or an R&D-focused environment
• Strong knowledge of U.S. GAAP
• Experience with financial close…